Search results for "gla"

showing 10 items of 4378 documents

Real-time control for transscleral cyclophotocoagulation.

1998

• Background: In transscleral cyclophotocoagulation, the surgeon cannot directly observe the applied laser effects. Overdosage, possibly resulting in unwanted pop effects, or underdosage with no therapeutic effect therefore often occur. • Method and materials: Laser radiation passing through the sclera and ciliary body is partly reflected from the fundus and can be monitored from outside the eye by a detector system. Since all other parameters influencing the intensity of the recorded radiation are constant in time during one laser exposure, the time dependence of this radiation directly reflects the change of transmission of the treated tissue. The laser exposure therefore can be stopped b…

AdultMalemedicine.medical_specialtygenetic structuresSwineGlaucomaFundus (eye)Signallaw.inventionCellular and Molecular NeuroscienceCiliary bodyPostoperative ComplicationslawTransmission curveOphthalmologymedicineCadaverAnimalsHumansAgedLaser Coagulationbusiness.industryCiliary BodyGlaucomaMiddle AgedLasermedicine.diseaseeye diseasesSensory SystemsIntensity (physics)ScleraOphthalmologymedicine.anatomical_structureTreatment OutcomeFemalesense organsSafetybusinessScleraGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
researchProduct

Long-term follow-up of a multifocal apodized diffractive intraocular lens after cataract surgery.

2007

Purpose To report the long-term performance of the AcrySof ReSTOR SA60D3 intraocular lens (IOL) after cataract surgery. Setting University Hospital Maastricht, Maastricht, The Netherlands. Methods This prospective clinical trial comprised 44 eyes (22 consecutive patients) having cataract surgery with implantation of the ReSTOR IOL. Monocular and binocular uncorrected distance visual acuity, best corrected distance visual acuity, uncorrected near visual acuity, best distance-corrected near visual acuity, spectacle dependence, undesired visual symptoms, patient satisfaction, and incidence of posterior capsule opacification were analyzed 6 months and 3 years postoperatively. Results The mean u…

AdultMalemedicine.medical_specialtygenetic structuresmedicine.medical_treatmentEye diseaseAcrylic ResinsVisual AcuityIntraocular lensRefraction OcularCataractContrast SensitivityPatient satisfactionLens Implantation IntraocularOphthalmologySurveys and QuestionnairesmedicineHumansProspective StudiesProspective cohort studyAgedAged 80 and overLenses IntraocularVision BinocularPhacoemulsificationbusiness.industryGlare (vision)PhacoemulsificationCataract surgeryMiddle Agedmedicine.diseaseeye diseasesSensory SystemsSurgeryOphthalmologyTreatment OutcomePatient SatisfactionCapsulotomyQuality of LifeOptometrySurgeryFemalesense organsbusinessFollow-Up StudiesJournal of cataract and refractive surgery
researchProduct

Ciclosporin and thyroid-stimulating immunoglobulins in endocrine orbitopathy.

1989

The study investigated whether ciclosporin (C) affected the thyroid-stimulating immunoglobulins (TSI) in serum of patients with endocrine orbitopathy (EO). The effect of C was compared with that of prednisone (P). Fifteen patients with EO classes III-V received C (n = 7) or P (n = 8). In addition to the immunosuppressants, five patients with Graves' disease in each group received methimazole (MMI). The stimulation of the cAMP levels in the medium of thyrocyte cultures was determined as a parameter of TSI. The TSI levels were markedly lowered in both groups during and after therapy. C group: before therapy 6.2 pmol/ml +/- 1.63 (100%, mean +/- SEM), during treatment 4.6 pmol/ml +/- 2.28 (74%)…

AdultMalemedicine.medical_specialtymedicine.drug_classGraves' diseasemedicine.medical_treatmentThyroid GlandCyclosporinsPrednisoneInternal medicinemedicineCyclic AMPExophthalmosHumansAgedChemotherapyTriiodothyronineMethimazolebusiness.industryThyroidGeneral MedicineMiddle Agedmedicine.diseaseCiclosporinGraves DiseaseTiterEndocrinologymedicine.anatomical_structureImmunoglobulin GCorticosteroidPrednisoneTriiodothyronineFemalebusinessmedicine.drugImmunoglobulins Thyroid-StimulatingResearch in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie
researchProduct

Adrenalectomy for Bilateral and Recurrent Pheochromocytoma: Increased Intraoperative Risk?

2006

Adrenalectomy for pheochromocytoma is per se associated with a specific intraoperative cardiovascular risk caused by catecholamine secretion during manipulation of the tumor. Bilateral or multiple, and recurrent chromaffine tumors are special subentities with a potentially more intensified and longer surgical preparation. The aim of our study was to examine these effects on hemodynamic changes compared with those observed for primary, solitary tumors. Of the 82 studied interventions between February 1992 and May 2005, 58 were seen to involve primary, unilateral tumors, 17 involved bilateral (1 trilateral) findings, and there were 7 cases of recurrency. The hemodynamic changes related to pri…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAdrenal Gland NeoplasmsUrologyHemodynamicsBlood PressurePheochromocytomaHypertension MalignantPheochromocytomaCatecholaminesMaximum blood pressureRisk FactorsmedicineHumansIntraoperative ComplicationsVeinLigatureAgedRetrospective StudiesAdrenal glandbusiness.industryAdrenalectomyAdrenalectomyGeneral MedicineMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureBlood pressureFemaleNeoplasm Recurrence LocalbusinessFollow-Up StudiesThe American Surgeon
researchProduct

Long-Term Results of Endoscopic Adrenalectomy for Conn's Syndrome

2007

The long-term effect of adrenalectomy on aldosterone-producing adenomas of the adrenal gland is controversially discussed. The aim of this study was to analyze the long-term course, with special consideration of factors of persisting hypertension after endoscopic adrenalectomy, for Conn's syndrome. Between February 1994 and March 2004, 40 patients with Conn's syndrome underwent endoscopic adrenalectomy. Data were recorded prospectively. Adrenalectomy was carried out unilaterally in all patients. Twenty-three patients (57.5%) were women; the median age was 51.7 (31.2–71.4) years. Preoperatively, all patients presented with arterial hypertension persisting over a median period of 84 (5–240) …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentEssential hypertensionchemistry.chemical_compoundHyperaldosteronismmedicineHumansConn SyndromeAgedRetrospective StudiesAldosteronemedicine.diagnostic_testbusiness.industryAdrenal glandAdrenalectomyAdrenalectomyEndoscopyRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseEndoscopySurgeryConn's syndromeTreatment Outcomemedicine.anatomical_structurechemistryHypertensionFemalebusinessFollow-Up StudiesThe American Surgeon
researchProduct

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo…

2001

To study the efficacy of coumarin/troxerutine for the protection of salivary glands and mucosa during irradiation. Design: Prospective, randomized, placebo-controlled, double-blind trial. Setting: University hospital, Germany. Patients: 48 patients who had radiotherapy to the head and neck. Main outcome measures: Salivary gland scintigraphy and acute side-effects of radiotherapy (Radiation Therapy Oncology Group (RTOG) score). Results: 23 patients (11 experimental, 12 placebo) completed the study. The global efficacy measure combining scintigraphy and RTOG score favoured the experimental arm (P= 0.07). The RTOG score showed significantly fewer acute side-effects of radiation in the experime…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRadiation-Protective AgentsPlaceboGastroenterologyXerostomiaSalivary GlandsSialadenitislaw.inventionRandomized controlled trialDouble-Blind MethodlawCoumarinsInternal medicinemedicineMucositisHumansProspective StudiesProspective cohort studyRadiation InjuriesRadionuclide ImagingAgedSodium Pertechnetate Tc 99mbusiness.industryHead and neck cancerMouth MucosaMiddle Agedmedicine.diseaseSialadenitisSurgeryRadiation therapyDrug CombinationsHydroxyethylrutosideTreatment OutcomeOtorhinolaryngologyEpidermoid carcinomaHead and Neck NeoplasmsSurgeryFemaleOral SurgeryCranial IrradiationRadiopharmaceuticalsbusinessThe British journal of oralmaxillofacial surgery
researchProduct

Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs.

2005

Background. Venous ulcers represent an important medical problem due to their high prevalence and consequent sanitary costs. In this study we evaluated the effect of Prostaglandin E-1 (PGE-1), a drug that improves district ischemia, on the healing of venous ulcers. Methods. We performed a randomized, placebo-controlled, single blind study, in which 87 patients, carriers of venous leg ulcers, homogeneous for dimensions and characteristics, were treated for 20 days an with infusion of Prostaglandin E-1 or placebo, in association with a topic therapy. The dimension and the number of the ulcers were determined at the beginning of the treatment and then every 20 days up to 4 months or until tota…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentVasodilator AgentsIschemiaHealing timeProstaglandinPlacebolaw.inventionVaricose Ulcerchemistry.chemical_compoundRandomized controlled triallawMedicineHumansSingle-Blind MethodAlprostadilAgedLegUltrasonography Doppler DuplexWound Healingbusiness.industryMiddle Agedmedicine.diseasedigestive system diseasesSurgeryClinical trialchemistryBaseline characteristicsVenous ulcers Prostaglandine E-1SurgeryFemaleCardiology and Cardiovascular MedicinebusinessProstaglandin EJournal of vascular surgery
researchProduct

In vitro Analysis of Synergistic Effects of Fibrinolytic Agents and Prostacyclin Analogues

1997

We investigated the in vitro thrombolytic effects of streptoki-nase, urokinase, alteplase and saruplase, alone or in combination, with the prostacyclin analogues, iloprost and taprostene. Human platelet-rich plasma was stimulated with collagen (1 μg/ml) to generate thrombi containing platelets and fibrin. Following treatment with fibrinolytic agents, lysis was allowed to proceed for 30 min and was then terminated with aprotinin (2,000 ClU/ml). To evaluate the combinatory effects of fibrinolytic agents and prostacyclin analogues, we used concentrations of fibrinolytic agents which reduced thrombi weight by less than 50%. Neither iloprost nor taprostene alone demonstrated any thrombolytic eff…

AdultMalemedicine.medical_treatmentProstacyclinPharmacologyFibrinolytic AgentsPhysiology (medical)Prostaglandins SyntheticFibrinolysismedicineHumansStreptokinaseIloprostUrokinaseChemistryFibrinolysisDrug SynergismHematologyDrug interactionEpoprostenolUrokinase-Type Plasminogen ActivatorIn vitroTissue Plasminogen Activatorcardiovascular systemFemaleSaruplaseFibrinolytic agentIloprostmedicine.drugPathophysiology of Haemostasis and Thrombosis
researchProduct

Autoimmune polyglandular syndrome type 2 shows the same HLA class II pattern as type 1 diabetes†

2011

Autoimmune polyglandular syndrome (APS) type 2 is defined by the manifestation of at least two autoimmune endocrine diseases. Only few data exist on genetic associations of APS type 2. In this controlled study, 98 patients with APS type 2, 96 patients with type 1 diabetes (T1D), and 92 patients with autoimmune thyroid disease, both as a single autoimmune endocrinopathy, were tested for association with alleles of the human leukocyte antigen (HLA) class II loci DRB1, DQA1, and DQB1. Patients with APS type 2 had significantly more often the alleles DRB1*03 (P(c) < 0.0001), DRB1*04 (P(c) < 0.000005), DQA1*03 (P(c) < 0.0001), and DQB1*02 (P(c) < 0.05), when compared with controls. Less frequent…

AdultMalemusculoskeletal diseasesendocrine system diseasesImmunologyHuman leukocyte antigenDiseaseBiochemistryGene Frequencyimmune system diseasesDiabetes mellitusGeneticsmedicineHumansImmunology and AllergyEndocrine systemAllelePolyendocrinopathies Autoimmuneskin and connective tissue diseasesAllelesHLA-D AntigensType 1 diabetesbusiness.industryHaplotypenutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseDiabetes Mellitus Type 1ImmunologyAutoimmune Polyglandular Syndrome Type 2FemalebusinessTissue Antigens
researchProduct

Incidence rate of metastases in the oral cavity: a review of all metastatic lesions in the oral cavity

2021

Background Metastases in the oral cavity are rare and account for only 1 to 3% of all malignant lesions in this area. The primary location from which most metastases have been described in the oral cavity in adult patients include lungs, breasts, kidneys and colon. Material and Methods A systematic search of the literature was carried out following the PRISMA statement in PubMed database. Clinical trials and case series published in the last 10 years [2010-2020] were eligible to be selected. The headings and keywords used in the searches were “cancer” AND “oral metastases”, “incidence” AND “oral metastases”, “oral metastases” AND “jaw bone”, “oral metastases” AND “soft tissue”. Results For …

AdultMalepleomorphic adenomamedicine.medical_specialtyReviewMetastasisMetàstasiProstateOral Cancer and Potentially malignant disorderssublingual glandHumansMedicineadenoid cystic carcinomaGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective Studiesbusiness.industryOral cancerIncidenceIncidence (epidemiology)ThyroidSoft tissueCancerRetrospective cohort studymedicine.diseasePrimary tumorCàncer de bocamucoepidermoid carcinomaClinical trialsalivary gland neoplasmsmedicine.anatomical_structureJawOtorhinolaryngologyMouth NeoplasmsSurgeryRadiologybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct